18F-Fdg-Pet/Ct 37
Accessory breast tissue 1
Adalimumab 94
Adverse event 155
Aggressive 381
Angiolipoma 371
Angiosarcoma 190
Anthracyclines 299
Arab culture 329
Arfi elastography 134
Artificial intelligence 203
Axilla 163, 195
Axillary dissection 163, 289
Axillary lymph node metastases 37, 203
Axillary reverse lymphatic mapping 1
Axillary ultrasound 37
Barriers 329
Benign 248
Bioempedance spectroscopy 148
Biomarkers 235
Body mass index 271
Bone metastasis 286
BRCA mutations 323
Breast 30, 172, 190, 279, 343, 360, 371
Breast calcification 13
Breast cancer 1, 6, 63, 74, 79, 85, 91, 105, 134, 141, 148, 155, 167, 182, 199, 222, 229, 235, 252, 258, 292, 306, 315, 375
Breast cancer risk 108
Breast cancer screening 79
Breast cancer screening behaviors 329
Breast cancer surgery 55
Breast carcinoma 271, 289
Breast carcinomas 336
Breast conserving therapy 127
Breast disease 248
Breast imaging 286
Breast implant 381
Breast lesions 48
Breast mass 381
Breast reconstruction 105
Breast ultrasonography 163, 199
Breast-conserving surgery 315
Breast-conserving therapy 55
Breast-Q 127
Cancer 172, 203
Cardiotoxic agents 299
Care pathway 222
Case report 94
Cd3D 141
Chemotherapy 289, 299
Chest scan 91
Cholesterol 108
Circumferential volume measurement 148
Citation 258
Clinical features 360
Clinical practices 205
Colonic metastasis 375
Contralateral prophylactic mastectomy 16
COVID-19 306
Covid-19 74, 85, 91, 289
Cystic neutrophilic granulomatous mastitis 94
De novo breast cancer 85
De-escalation 6
Desmoid 381
Diagnostic performance 37
Dietary fat intake 108
Direct-to-implant reconstruction 55
Ductal carcinoma in situ 205, 336
Ductography 279
ECG 299
Elastin fiber 134
Estrogen receptor 167
Extra-mammary 252
Fat grafting 105
Fibroadenoma 134
Fibromatosis 381
Foxo1 141
Galactocele 102
Gastric metastasis 375
Gastrointestinal tract metastasis 375
Gata3 expression 229
Genetic counseling 16
Germline brca mutation 16
Granulomatous mastitis 195
Gynecomastia 371
Hemangioma 190
HER2 315
Her2 63
Hereditary breast cancer 16
Histopathological findings 360
Histopathology 229
Hormonal therapy 155, 292
Hyperprolactinemia 102
Idiopathic granulomatous mastitis 94
Il-2 141
Il-2Ra 141
Immediate breast reconstruction 55
Immunohistochemistry 21, 229
Implant-based reconstruction 55
In silico analysis 235
In situ 343
Indeterminate lesion 252
Innovative approaches 205
Intraductal 371
Intraductal carcinoma 343
Intraductal proliferations 279
Invasive ductal carcinoma 271
Invasive lobular carcinoma 375
Invasive papillary carcinoma 360
Kidney injury molecule-1 336
Lupus erythematosus 13
Lupus mastitis 13
Lymphedema 148
Machine learning 203
Magnetic resonance imaging 172, 199
Male 371
Male breast cancer 199, 323
Malignant 343
Mammography 172, 199
Mastalgia 248
Metastasis 252, 286
Metastatic cancer 85
Mir-490 141
Molecular subtype 353
Molecular subtypes of breast carcinoma 271
Mono-unsaturated fatty acid 108
Mri 37, 79, 190
Mucinous 30
Mucinous carcinoma 353
Mucormycosis 289
Muslim Arab Iraqi women 329
Neo-adjuvant therapy 6
Neoadjuvant chemotherapy 167, 271, 289
Neoadjuvant systemic therapy 306
Neuroendocrine 30
Neutrophil gelatinase-associated lipocalin 336
New version 48
Nfat5 141
Nipple eczema 102
Oncology department 74
Oncoplastic reconstruction 127
Pandemic 85
Panniculitis 13
Papilloma 371
Pathological complete response 271
Pathology features 323
Patient reported outcome 155
Patient satisfaction 63, 127
Patient-related delay time 85
Personal health records 155
Phldb 235
Phyllodes tumors 343
Positive lymph nodes 163
Precision medicine 205
Prediction 203
Pregnancy 195
Progesterone receptor 167
Prognosis 323, 336, 353
Programmed cell death protein 1 (Pd-1) 21
Programmed death-ligand 1 (Pd-L1) 21
Quality of life 155, 292
Quality-of-life 148
Radical lumpectomy 127
Radiomics 203
Receptor change 167
Recurrence 315
Research 258
Risk factors 79, 182
Risk-reducing salpingo-oophorectomy 16
Sars-Cov-2 74, 91
Saturated fatty acid 108
Screening 16, 91, 182
Sentinel lymph node biopsy 37
Sentinel node biopsy 163
Solid papillary 30
Staff viewpoint 222
Stereotactic core-needle biopsy 279
Subcutaneous 63
Success factors 222
Superb microvascular imaging 48
Surgery 195, 306
Survey 205
Survival 182
Synchronous neoplasms 199
Tertiary hospital 74
Trastuzumab 63
Treatment de-escalation 205
Triple-negative breast cancer 21, 315
Troponin I 299
Tumor necrosis factor alpha inhibitor 94
Turkish 148
Two-stage implantbased reconstructions 55
Ultrasonography 48
Ultrasound 172
Vus mutation 16
Women 292
Women’s health 48
